Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and Pfizer Inc. (NYSE: PFE) today announced an exclusive, global collaboration and license agreement for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments Trading Halts

Sangamo Biosciences (SGMO) Continues Thursday's MomentumMay 12, 2017 10:54 AM Sangamo Therapeutics Reports First Quarter 2017 Financial ResultsMay 10, 2017 4:01 PM Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene TherapyMay 10, 2017 4:01 PM Sangamo Biosciences (SGMO) Halted, News PendingMay 10, 2017 4:00 PM